Post-viral syndrome · 2026
Long COVID care in China,
comprehensive workup, honest expectations.
Multidisciplinary workup of post-acute sequelae of SARS-CoV-2 (PASC): cardiac, pulmonary, autonomic, cognitive, and chronic fatigue assessment. Multimodal symptomatic management with integrative TCM where evidence supports it. No miracle cures.
$1,400–2,800
Comprehensive workup
Multi-system assessment with bilingual report
Partner clinic quotes 2024
MDT
Standard pathway
Cardiology + pulmonology + neurology + rheumatology + clinical psychology
Standard at top centres
Class A
Top centres
PUMC, Huashan, Zhongshan integrated PASC clinics
NHC ratings
Trial pipeline
Active investigation
Multiple Chinese trials of low-dose naltrexone, rapamycin, antiviral persistence
NMPA registry
TCM
Adjunctive evidence
Modest evidence for fatigue / sleep / cognitive symptoms
Centre programs
Honest
No miracle cures
Evidence-based positioning; trials clearly disclosed as investigational
Editorial standard
Tiers & pricing
Six tiers, transparent pricing.
Comprehensive PASC workup
History, symptom mapping, cardiac (ECG, echo, troponin), pulmonary (PFT, 6MWT, chest CT), autonomic (HUTT, COMPASS-31), cognitive (MoCA, neuropsych).
$1,400–2,800
Cardiac evaluation
Workup of POTS, IST, myopericarditis, microvascular dysfunction. Cardiac MRI in selected.
$650–1,800
Pulmonary rehabilitation
PFT-guided structured aerobic + breath training; pacing for exertional intolerance / PEM.
$1,200–2,500 / 4 wk
Autonomic / POTS care
Salt + fluid loading, compression, pyridostigmine, ivabradine, beta-blocker, midodrine — case-tailored.
Quoted on case
Cognitive / mental health
Neuropsych assessment, sleep optimization, CBT for fatigue, structured cognitive rehab.
Quoted on case
Clinical trials
Low-dose naltrexone, rapamycin, antiviral persistence (Paxlovid extended), microbiome modulation.
Trial-dependent
Top hospitals
Six centres
open to international patients.
PUMC PASC Clinic 北京协和医院
Academic MDT · cardiology + pulmonology + neurology + rheumatology integration
Huashan Hospital 华山医院
Class A · neurology depth · cognitive and autonomic dysfunction expertise
Zhongshan PASC Clinic 中山医院
Class A · MDT post-COVID program · trial site
China-Japan Friendship Hospital 中日友好医院
Strong respiratory medicine · pulmonary rehab program · TCM cross-referral
Shanghai Public Health Clinical Center 上海市公共卫生临床中心
Class A specialty · large post-COVID cohort · trial leader
United Family Hospitals 和睦家
JCI · expat-focused · routine PASC follow-up · symptom management
FAQ
Frequently asked questions.
- What is Long COVID and how is it diagnosed?
- Long COVID (post-acute sequelae of SARS-CoV-2 / PASC) is symptoms persisting > 12 weeks after acute COVID-19 not explained by alternative diagnosis. Common manifestations: fatigue and post-exertional malaise; cognitive dysfunction ('brain fog'); cardiopulmonary symptoms (dyspnea, palpitations, chest pain, POTS); autonomic dysfunction; sleep disturbance; sensory changes (smell / taste); pain. Diagnosis is clinical — there is no specific biomarker. Standard workup excludes alternative diagnoses (cardiac, pulmonary, endocrine, autoimmune, hematologic) before symptomatic care.
- Why China for Long COVID?
- Three reasons: (1) Volume — China has a very large PASC patient pool from the 2022–2023 outbreak waves and academic centres have built MDT clinics with structured workup; (2) Trial pipeline — multiple late-phase Chinese trials of low-dose naltrexone, rapamycin, antiviral persistence (Paxlovid, ensitrelvir extended courses), microbiome modulation, mitochondrial support; (3) Integrative TCM — Chinese academic centres have published the largest cohorts evaluating TCM in PASC, with modest evidence supporting adjunctive use for fatigue, sleep, and cognitive symptoms.
- What does a comprehensive workup include?
- Standard 3–5 day pathway: detailed history with symptom mapping; cardiac (ECG, echo, troponin, BNP, cardiac MRI in selected); pulmonary (spirometry, lung volumes, DLCO, 6MWT, high-res chest CT); autonomic (head-up tilt test, COMPASS-31, NASA Lean Test); cognitive (MoCA, formal neuropsychometric testing); rheumatology (autoimmune panel if joint or systemic symptoms); endocrine (thyroid, adrenal, sex hormones, IGF-1); sleep (PSG if indicated); mental health (PHQ-9, GAD-7, structured assessment). Bilingual MDT report.
- What treatments actually work?
- We are explicitly conservative on this question — large randomised evidence is limited. Symptomatic management with established evidence: pacing for PEM (Bateman Horne Center protocol); structured pulmonary rehab for dyspnea and deconditioning (where PEM is absent); POTS-targeted therapy (volume + compression + ivabradine, beta-blocker, midodrine, pyridostigmine); CBT for sleep and mood (with caveats — not a treatment for the underlying disease); migraine and pain protocols where applicable. Investigational: low-dose naltrexone has small published cohorts suggesting symptomatic benefit; rapamycin trials underway. We do not recommend ozone, hyperbaric oxygen as primary therapy, or stem cell injection for Long COVID.
- What about the trial pipeline?
- Multiple active Chinese Long COVID trials as of late 2025: (1) Low-dose naltrexone for fatigue and pain — Phase II / III; (2) Rapamycin / sirolimus for inflammation and senescence — Phase II; (3) Antiviral persistence trials (extended Paxlovid, ensitrelvir) testing whether residual viral antigen drives PASC; (4) IL-6 receptor antagonist trials for hyperinflammatory phenotype; (5) Microbiome modulation; (6) TCM formulation trials. Eligibility screening costs $450–$950 and matches against your specific phenotype.
- What about TCM in Long COVID?
- TCM is offered as adjunctive therapy at most Class A integrated PASC centres. Evidence is limited but improving — published Chinese RCTs and observational studies suggest modest benefit for fatigue, sleep and cognitive symptoms with specific formulations (Lianhua Qingwen, Shufeng Jiedu, post-COVID-specific custom formulations). We position TCM as adjunctive only — not curative — and screen for drug interactions with any prescribed medication. Acupuncture has slightly stronger evidence for fatigue and cognitive symptoms specifically.
Related guides
Longevity Medicine
Cardiometabolic optimization as part of recovery.
Read the guideSleep Medicine
Sleep dysfunction is common in Long COVID.
Read the guideClinical Trials
Trial screening for active Long COVID protocols.
Read the guideIntegrative TCM
Where TCM has evidence in post-viral syndrome.
Read the guideRecords Translation
Bilingual MDT workup and treatment plan.
Read the guideSecond Opinion
Independent multidisciplinary second opinion from $250.
Read the guideSend your symptom timeline
for a multidisciplinary review.
Tell us your acute COVID timeline and persistent symptoms. We coordinate a multidisciplinary workup at a partner Class A centre, with bilingual report and trial-eligibility shortlist if applicable.
This page is for general information only and does not constitute medical advice. Long COVID is a heterogeneous syndrome without specific cure as of 2026. We do not promise recovery and explicitly disclose investigational therapies as such. New chest pain, breathlessness or neurological symptoms warrant urgent medical evaluation.